Arkolith/Insider Trading/CKPT/Form 4

Oliviero James F III

CEO, President and Director, DirectorCheckpoint Therapeutics, Inc. (CKPT) · full profile →Form 4 · filed Feb 2, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24K
Net Open-Market Flow
-$24K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2024Gift(G)13K—$0357K
Feb 1, 2024Sell(S)12K$2.01$24K370K

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-010265) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML